GLP-1 Receptor Agonist Use Linked to Lower Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease
Use of GLP-1 receptor agonist was significantly associated with a lower 5-year incidence of colorectal cancer among patients…
Browsing Category